U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. 2024 Center for Biologics Evaluation and Research (CBER) Science Symposium - 09/16/2024
  1. FDA Meetings, Conferences and Workshops

Public | Virtual

Event Title
2024 Center for Biologics Evaluation and Research (CBER) Science Symposium
September 16 - 18, 2024

Date:
September 16 - 18, 2024
Time:
9:30 AM - 4:00 PM ET

PURPOSE OF PUBLIC SYMPOSIUM

The purpose of the public symposium is to discuss scientific topics related to the regulation of biologics and highlight science conducted at CBER by showcasing how scientific research informs regulatory decision making, and to provide a forum for developing collaborations within FDA and with external organizations. The symposium will include presentations by experts from academic institutions, government agencies and research institutions.

SUPPLEMENTARY INFORMATION

Topics for Discussion

The public symposium will include presentations on the following topics: (1) emerging and re-emerging diseases; (2) advanced manufacturing and analytics, including new and emerging technologies; (3) immune response to vaccination; (4) methods and biomarker discovery for product safety and quality; (5) advances in computational science supporting biologics evaluation; and (6) cell, tissue and gene therapy.

LOCATION 

The hybrid public symposium will be held at FDA’s White Oak campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993 AND virtually (link will be provided in your confirmation email).  Entrance for the public symposium participants (non-FDA employees) is through Bldg.1, where routine security check procedures will be performed.  For parking and security information, please refer to Visitor Information | FDA 
If you need special accommodations due to a disability, please contact Loni Warren Henderson no later than September 2, 2024 at CBERPublicEvents@fda.hhs.gov (subject line: 2024 CBER Science Symposium).

REGISTRATION

***After registering, you will receive a confirmation email containing information about joining the webinar.

FOR FURTHER INFORMATION CONTACT:

Loni Warren Henderson, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 1118, Silver Spring, MD 20993, 240-402-8020, CBERPublicEvents@fda.hhs.gov (subject line: 2024 CBER Science Symposium)

Event Materials

Title File Type/Size
2024 Center for Biologics Evaluation & Research (CBER) Science Symposium Agenda pdf (416.43 KB)
Back to Top